Status:
COMPLETED
Remediation of Emotional Deficits in Multiple Sclerosis and Traumatic Brain Injury
Lead Sponsor:
Kessler Foundation
Conditions:
Multiple Sclerosis
Traumatic Brain Injury
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study will examine the efficacy of a clinical intervention for improving emotional processing in individuals with MS and TBI.(1)The main outcome measure will be changes in emotional processing me...
Eligibility Criteria
Inclusion
- diagnosis of Multiple Sclerosis or Traumatic Brain Injury
- Fluent in English
- processing speed impairment (based on evaluation)
Exclusion
- currently taking steroids and/or benzodiazepines
- prior stroke or neurological diease
- history of significant pyschiatric illness (for example, bipolar disorder, schizophrenia, or psychosis) or a current diagnosis of Major Depressive Disorder, Schizophrenia, Epilepsy, Bipolar Disorder
- significant alcohol or drug abuse history
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2017
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04408274
Start Date
May 1 2013
End Date
August 1 2017
Last Update
May 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kessler Foundation
East Hanover, New Jersey, United States, 07936